Generate a tailored SOP for Dr. Yang De Marinis. Improve your application with a focused, well-structured draft.
Yang De Marinis is an Associate Professor at Lund University, where he leads research in the Department of Clinical Sciences. His work primarily focuses on the epigenetics of diabetes complications and the development of biomarkers and diagnostic tools. Aimed at improving clinical outcomes, his group utilizes cutting-edge technologies such as genome-wide chromatin immunoprecipitation sequencing, CRISPR/Cas9 genome engineering, and artificial intelligence in clinical cohort studies. De Marinis is also recognized for his role as a visiting scientist at the University of Oxford and a chair professor at Shandong University in China, reflecting his international collaboration and influence. In 2020, he founded Lundoch Diagnostics, a MedTech company that gained recognition among young tech companies in Sweden by 2022. He actively participates in various research initiatives, and is a member of the board for Diabetes Sverige, demonstrating his commitment to advancing diabetes research and management. His expertise aligns with multiple United Nations Sustainable Development Goals, particularly those aimed at ending poverty and ensuring good health and well-being.
Lund University • Lund, Sweden
Leading research on diabetes and epigenetics within the Department of Clinical Sciences.
Shandong University • Shandong, China
Visiting role focusing on diabetes research.
Includes Master of Science in Politics and Society of the Contemporary Middle East and European Affairs.